Phosphorylation‐ and stimulus‐dependent inhibition of cellular 5‐lipoxygenase activity by nonredox‐type inhibitors
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Nonredox‐type 5‐lipoxygenase (5‐LO) inhibitors such as ZM230487 or L‐739.010 potently suppress leukotriene biosynthesis at low cellular peroxide tone. Here, we show that inhibition of 5‐LO product formation by nonredox‐type 5‐LO inhibitors in human isolated polymorphonuclear leukocytes (PMNL) depends on the activation pathway of 5‐LO. Thus, compared with 5‐LO product synthesis induced by the Ca 2+ ‐mobilizing agent ionophore A23187, cell stress‐induced 5‐LO product formation involving 5‐LO kinase pathways required ∼10‐ to 100‐fold higher concentrations of ZM230487 or L‐739.010 for comparable 5‐LO inhibition. No such differences were observed for the iron ligand‐type 5‐LO inhibitor BWA4C or the novel‐type 5‐LO inhibitors hyperforin and 3‐ O ‐acetyl‐11‐keto‐boswellic acid. Experiments using purified 5‐LO revealed that Ca 2+ is no prerequisite for potent enzyme inhibition by ZM230487, and exposure of PMNL to the combination of ionophore and cell stress did not restore potent 5‐LO suppression. Intriguingly, a significant difference in the potency of nonredox‐type inhibitors (but not of BWA4C) was determined between wild‐type 5‐LO and the mutant S271A/S663A‐5‐LO (lacking phosphorylation sites for ERK1/2 and MAPKAPK‐2) in HeLa cells. Collectively, our data suggest that compared with Ca 2+ ‐mediated 5‐LO product formation, enzyme activation involving 5‐LO phosphorylation events specifically and strongly alters the susceptibility of 5‐LO toward nonredox‐type inhibitors in intact cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mehrabian, M., Allayee, H., Wong, J., Shih, W., Wang, X.-P., Shaposhnik, Z., Funk, C. D., & Lusis, A. J. (2002) · Circulation Research · doi:10.1161/01.res.0000028008.99774.7f · Cited by 422 · cited 2×
“Based on the recently discovered effects of 5-LO metabolites to promote proliferation and survival of malignant cells, bone resorption and atherosclerosis, 5-LO inhibitors, may also possess potential for prevention and therapy of cancer (4, 26, 27), osteoporosis (28), and vascular diseases (9).”
Background
Cited by
5-Lipoxygenase: regulation of expression and enzyme activity
Rådmark, O., Werz, O., Steinhilber, D., & Samuelsson, B. (2007) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2007.06.002 · Cited by 471
Self-citationTherapeutic options for 5-lipoxygenase inhibitors
Werz, O., & Steinhilber, D. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2006.05.009 · Cited by 260
Self-citationTargeting biosynthetic networks of the proinflammatory and proresolving lipid metabolome
Werner, M., Jordan, P. M., Romp, E., Czapka, A., Rao, Z., Kretzer, C., Koeberle, A., Garscha, U., Pace, S., Claesson, H., et al. (2019) · The FASEB Journal · doi:10.1096/fj.201802509r · Cited by 156
Self-citationWerz, O., Seegers, J., Schaible, A. M., Weinigel, C., Barz, D., Koeberle, A., Allegrone, G., Pollastro, F., Zampieri, L., Grassi, G., et al. (2014) · PharmaNutrition · doi:10.1016/j.phanu.2014.05.001 · Cited by 131
Self-citationAllegrone, G., Pollastro, F., Magagnini, G., Taglialatela-Scafati, O., Seegers, J., Koeberle, A., Werz, O., & Appendino, G. (2017) · Journal of Natural Products · doi:10.1021/acs.jnatprod.6b01126 · Cited by 36
Self-citation
Metadata
- Authors
- Fischer, L., Szellas, D., Rådmark, O., Steinhilber, D., & Werz, O.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2003-03-28
- Volume
- 17
- Issue
- 8
- Pages
- 1-24
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2160474109
- Cited by
- 141
- References
- 1
- FWCI
- 2.59
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Phosphorylation‐ and stimulus‐dependent inhibition of cellular 5‐lipoxygenase activity by nonredox‐type inhibitors. https://app.cochat.ai/papers/10.1096/fj.02-0815fje
- The paper
- Fischer, L., Szellas, D., Rådmark, O., Steinhilber, D., & Werz, O. (2003). Phosphorylation‐ and stimulus‐dependent inhibition of cellular 5‐lipoxygenase activity by nonredox‐type inhibitors. The FASEB Journal. https://doi.org/10.1096/fj.02-0815fje
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.